Futura Medical Shares Rise on Response to US Regulator for MED3000
By Joe Hoppe
Futura Medical PLC shares rose Wednesday after it said it has submitted a full response to the U.S. Food and Drug Administration's questions on its MED3000 gel formulation for the treatment of erectile dysfunction.
Shares at 0847 GMT were up 4.45 pence, or 10% at 46.95 pence.
The pharmaceutical company said is has also sent the requested confirmatory data, which together with the response, has been resubmitted to enable the FDA to continue its review of MED3000.
The company had said on March 14 that the FDA has asked additional questions and requested some nonclinical confirmatory data related to its application for marketing authorization for MED3000.
"Based on the FDA's published target review period guidelines which includes time to review the newly provided information, the board continue to anticipate grant of the... request in [the second quarter of] 2023," the company said.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
March 29, 2023 05:06 ET (09:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings Beat Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth
-
10 Best Blue-Chip Stocks to Buy for the Long Term
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
ServiceNow Earnings: Strong Quarter With In-Line Guidance and Increasingly Attractive Valuation
-
Ford Earnings: Pro Continues to Impress While EV Costs Are Contained
-
Boeing Earnings: Paying for Mistakes Made Long Ago, Taking Back the Factory Floor